FdaApplication

ANDA 215334

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL EU LTD
application_typeANDA
approval_date2023-07-24

Products (1)

ProductActive ingredientStrengthDosage form
PLERIXAFORPLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION;SUBCUTANEOUS

1 product